相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease
Mauro Ursino et al.
PLOS ONE (2020)
Levodopa in Parkinson's Disease: Current Status and Future Developments
Nicola Tambasco et al.
CURRENT NEUROPHARMACOLOGY (2018)
Simultaneous determination of levodopa and 3-O-methyldopa in patients with parkinson's disease by high-performance liquid chromatography with electrochemical detection
Urszula Adamiak-Giera et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2018)
Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis
Amelie Marsot et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2017)
A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients
N. Simon et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Risk and course of motor complications in a population-based incident Parkinson's disease cohort
Anders Bjornestad et al.
PARKINSONISM & RELATED DISORDERS (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Clinical Spectrum of Levodopa-Induced Complications
Camila Catherine Aquino et al.
MOVEMENT DISORDERS (2015)
'Don't delay, start today': delaying levodopa does not delay motor complications
Susan H. Fox et al.
BRAIN (2014)
The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson's Disease
Simone M. R. Camargo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease
Urszula Adamiak et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease Meta-Analysis of Randomized Controlled Trials
Jaime Kulisevsky et al.
DRUG SAFETY (2010)
Pharmacokinetics of levodopa
Manuela Contin et al.
JOURNAL OF NEUROLOGY (2010)
Relief of parkinsonism and dyskinesia One and the same dopaminergic mechanism?
Peter A. LeWitt
NEUROLOGY (2010)
Levodopa: Past, Present, and Future
Robert A. Hauser
EUROPEAN NEUROLOGY (2009)
Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: The view of an eyewitness
Oleh Hornykiewicz
NEURODEGENERATIVE DISEASES (2008)
The role of 3-O-methyldopa in the side effects of L-dopa
Eun-Sook Y. Lee et al.
NEUROCHEMICAL RESEARCH (2008)
Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: Results of two randomized studies in patients with Parkinson's disease
Debra J. Tompson et al.
CLINICAL THERAPEUTICS (2007)
Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software
Marc Lavielle et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease
Soo-Peang Khor et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Karl Brendel et al.
PHARMACEUTICAL RESEARCH (2006)
Rapid and sensitive liquid chromatography-mass spectrometry method for determination of ropinirole in human plasma
J Bhatt et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Pharmacokinetic optimisation in the treatment of Parkinson's disease - An update
D Nyholm
CLINICAL PHARMACOKINETICS (2006)
Maximum likelihood estimation in nonlinear mixed effects models
E Kuhn et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2005)
Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection
C Saxer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
AL Whone et al.
ANNALS OF NEUROLOGY (2003)
Gastric emptying time and gastric motility in patients with Parkinson's disease
R Hardoff et al.
MOVEMENT DISORDERS (2001)
Clinical pharmacokinetics of ropinirole
CM Kaye et al.
CLINICAL PHARMACOKINETICS (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
